Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA …
Economic Times NEW DELHI: Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and Drug … |
View full post on asthma – Google News